福元医药(601089) - 2024 Q3 - 季度财报

Revenue and Profit Performance - Revenue for the third quarter was RMB 891.53 million, a 7.02% increase compared to the same period last year[2] - Total operating revenue for the first three quarters of 2024 reached RMB 2,547,022,297.14, an increase from RMB 2,462,880,582.11 in the same period of 2023[15] - Net profit attributable to shareholders was RMB 110.33 million, a decrease of 14.74% year-over-year[2] - Net profit for the first three quarters of 2024 was RMB 404,081,251.12, up from RMB 383,031,171.23 in 2023[17] - Net profit attributable to parent company shareholders reached RMB 400,949,905.30, an increase of 5.6% compared to the same period last year[18] - Comprehensive income totaled RMB 404,081,251.12, up 5.5% year-over-year[18] Earnings Per Share (EPS) and Return on Equity (ROE) - Basic earnings per share (EPS) for the quarter was RMB 0.24, a decrease of 11.11% year-over-year[4] - Basic earnings per share (EPS) increased to RMB 0.85, up 7.6% from RMB 0.79 in the previous year[18] - Weighted average return on equity (ROE) for the quarter was 2.97%, a decrease of 0.95 percentage points year-over-year[4] Cash Flow and Financial Position - Operating cash flow for the first three quarters reached RMB 490.00 million, up 18.33% compared to the same period last year[2] - Cash flow from operating activities grew by 18.3% to RMB 490,004,394.07[19] - The company's monetary funds as of September 30, 2024, were 974,094,073.63 yuan, a decrease from 2,530,809,346.00 yuan at the end of 2023[12] - Cash and cash equivalents at the end of the period decreased by 60.6% to RMB 973,786,073.63[20] - Investment activities resulted in a net cash outflow of RMB 1,568,523,571.52, primarily due to significant cash payments related to other investment activities[20] - The company received RMB 1,145,998,981.92 from other investment-related activities, a significant increase compared to RMB 385,000,000.00 in the previous year[19] Assets and Liabilities - Total assets at the end of the reporting period were RMB 4.54 billion, a slight decrease of 0.24% compared to the end of the previous year[4] - Total assets as of Q3 2024 were RMB 4,536,654,003.08, slightly down from RMB 4,547,790,301.79 at the end of 2023[13] - Total liabilities as of Q3 2024 were RMB 1,068,549,101.43, a slight decrease from RMB 1,071,251,195.74 at the end of 2023[14] - Shareholders' equity as of Q3 2024 was RMB 3,468,104,901.65, compared to RMB 3,476,539,106.05 at the end of 2023[14] - Total non-current assets as of Q3 2024 were RMB 1,418,101,246.71, up from RMB 1,219,049,736.98 at the end of 2023[13] Operating Costs and Expenses - Operating costs for the first three quarters of 2024 were RMB 2,143,616,163.40, up from RMB 2,036,414,629.57 in 2023[17] - R&D expenses increased to RMB 297,591,745.37 in the first three quarters of 2024, compared to RMB 221,065,440.83 in 2023[17] - Sales expenses for the first three quarters of 2024 were RMB 917,476,764.29, slightly up from RMB 914,910,003.25 in 2023[17] - Interest income for the first three quarters of 2024 was RMB 32,122,065.94, down from RMB 43,179,389.79 in 2023[17] Non-Recurring Gains and Losses - Government subsidies received during the period amounted to RMB 2.25 million, contributing to non-recurring gains[5] - Bank financial product income contributed RMB 4.71 million to non-recurring gains[5] - Non-recurring gains and losses totaled RMB 4.84 million for the quarter[6] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 24,107[8] - New Hope Group holds 176,316,354 shares, accounting for 36.73% of the total shares[8] - Xinchang Qinjin Investment Co., Ltd. holds 98,337,233 shares, accounting for 20.49% of the total shares[8] - Beijing Huakang Taifeng Technology Co., Ltd. holds 70,240,881 shares, accounting for 14.63% of the total shares[8] - Hong Kong Securities Clearing Company holds 9,446,923 shares, accounting for 1.97% of the total shares[8] - The company repurchased 12,000,000 shares, accounting for 2.50% of the total shares, with a total payment of 176,169,816.92 yuan[10] Sales and Inventory - Sales revenue from goods and services reached RMB 2,516,657,281.73, a 6.8% increase year-over-year[19] - The company's accounts receivable as of September 30, 2024, were 347,584,668.10 yuan, slightly increased from 346,134,907.22 yuan at the end of 2023[12] - The company's inventory as of September 30, 2024, was 344,014,911.90 yuan, increased from 307,419,355.37 yuan at the end of 2023[12] Trading Financial Assets - The company's trading financial assets as of September 30, 2024, were 1,328,000,000.00 yuan[12]